Naider Avi Z.

Avg. Two Year Performance

39% Avg. Purchase Return
18% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return52%(6%)(< 1%)19%39%
Purchase Success Rate2 of 20 of 20 of 21 of 21 of 2
Average Sale Return(1%)(14%)(58%)(109%)0%
Sale Success Rate2 of 32 of 30 of 30 of 30 of 3

Loxo Oncology, Inc.

Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--